Cystic fibrosis lung environment and Pseudomonas aeruginosa infection
暂无分享,去创建一个
Maryam Dadashi | K. Duan | Kangmin Duan | Anjali Y. Bhagirath | Yanqi Li | Deepti Somayajula | Sara Badr | Anjali Y Bhagirath | Yanqi Li | Sara Badr | M. Dadashi | Deepti Somayajula
[1] H. Coutinho,et al. International Archives of Medicine BioMed Central Review , 2008 .
[2] M. Surette,et al. Phenotypic Heterogeneity of Pseudomonas aeruginosa Populations in a Cystic Fibrosis Patient , 2013, PloS one.
[3] G. Döring,et al. Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study , 2012, Thorax.
[4] F. Baquero,et al. Population Structure, Antimicrobial Resistance, and Mutation Frequencies of Streptococcus pneumoniae Isolates from Cystic Fibrosis Patients , 2005, Journal of Clinical Microbiology.
[5] R. Homer,et al. Increased susceptibility of Cftr-/- mice to LPS-induced lung remodeling. , 2016, American journal of physiology. Lung cellular and molecular physiology.
[6] J. Widdicombe,et al. CFTR and calcium-activated chloride channels in primary cultures of human airway gland cells of serous or mucous phenotype. , 2010, American journal of physiology. Lung cellular and molecular physiology.
[7] S. Lory,et al. A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa. , 2004, Developmental cell.
[8] J. M. Sauder,et al. Impact of the ΔF508 Mutation in First Nucleotide-binding Domain of Human Cystic Fibrosis Transmembrane Conductance Regulator on Domain Folding and Structure* , 2005, Journal of Biological Chemistry.
[9] J. Gustafson,et al. Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.
[10] Denis Wirtz,et al. Micro- and macrorheology of mucus. , 2009, Advanced drug delivery reviews.
[11] D. Hartl,et al. Update on host-pathogen interactions in cystic fibrosis lung disease , 2016, Molecular and Cellular Pediatrics.
[12] C. Basbaum,et al. The serous cell. , 1990, Annual review of physiology.
[13] A. Glanville,et al. The spectrum of mycobacterial infection after lung transplantation. , 1999, American journal of respiratory and critical care medicine.
[14] S. Bell,et al. Genotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic Fibrosis , 2015, PloS one.
[15] D. Sheppard,et al. Gating of the CFTR Cl− channel by ATP‐driven nucleotide‐binding domain dimerisation , 2009, The Journal of physiology.
[16] P. Hiatt,et al. Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[17] Jeffrey L. Curtis,et al. Analysis of the Upper Respiratory Tract Microbiotas as the Source of the Lung and Gastric Microbiotas in Healthy Individuals , 2015, mBio.
[18] Á. Mészáros,et al. Health Related Quality of Life of Children with Chronic Respiratory Conditions. , 2015, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.
[19] Kai Du,et al. Cooperative assembly and misfolding of CFTR domains in vivo. , 2009, Molecular biology of the cell.
[20] L. Delhaes,et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review. , 2009, Medical mycology.
[21] W. Meyer,et al. Fungal infections and treatment in cystic fibrosis , 2013, Current opinion in pulmonary medicine.
[22] G. McLennan,et al. Loss of cystic fibrosis transmembrane conductance regulator function produces abnormalities in tracheal development in neonatal pigs and young children. , 2010, American journal of respiratory and critical care medicine.
[23] J. Heesemann,et al. Marker genes for the metabolic adaptation of Pseudomonas aeruginosa to the hypoxic cystic fibrosis lung environment. , 2014, International journal of medical microbiology : IJMM.
[24] Emily Newman,et al. Self-Esteem and Its Relationship to Mental Health and Quality of Life in Adults with Cystic Fibrosis , 2013, Journal of Clinical Psychology in Medical Settings.
[25] R. Vance,et al. Recognition of bacteria by inflammasomes. , 2013, Annual review of immunology.
[26] R. Boucher,et al. CFTR and outward rectifying chloride channels are distinct proteins with a regulatory relationship , 1993, Nature.
[27] M. Schöni,et al. Nutrition and lung function in cystic fibrosis patients: review. , 2000, Clinical nutrition.
[28] L. Hoffman,et al. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience , 2012, Thorax.
[29] P. Reix,et al. Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[30] R. Castile,et al. Structural airway abnormalities in infants and young children with cystic fibrosis. , 2004, The Journal of pediatrics.
[31] E. Sorscher,et al. CFTR involvement in chloride, bicarbonate, and liquid secretion by airway submucosal glands. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[32] S. Ballard,et al. Liquid secretion properties of airway submucosal glands , 2004, The Journal of physiology.
[33] Y. Kong,et al. Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium , 2015, Nature Communications.
[34] Zhengrong Yang,et al. Integrated biophysical studies implicate partial unfolding of NBD1 of CFTR in the molecular pathogenesis of F508del cystic fibrosis , 2010, Protein science : a publication of the Protein Society.
[35] M. Valvano,et al. Depletion of the Ubiquitin-binding Adaptor Molecule SQSTM1/p62 from Macrophages Harboring cftr ΔF508 Mutation Improves the Delivery of Burkholderia cenocepacia to the Autophagic Machinery* , 2012, The Journal of Biological Chemistry.
[36] M. Kosorok,et al. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. , 1997, Pediatrics.
[37] M. Surette,et al. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections , 2016, PloS one.
[38] D. Benos,et al. CFTR regulation of epithelial sodium channel. , 2011, Methods in molecular biology.
[39] J. Carlin,et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. , 2001, The Journal of pediatrics.
[40] M. Surette,et al. Inactivation of MuxABC-OpmB transporter system in Pseudomonas aeruginosa leads to increased ampicillin and carbenicillin resistance and decreased virulence , 2011, The Journal of Microbiology.
[41] V. Vallon,et al. Molecular Mechanisms of Calcium-sensing Receptor-mediated Calcium Signaling in the Modulation of Epithelial Ion Transport and Bicarbonate Secretion* , 2014, The Journal of Biological Chemistry.
[42] M. Welsh. Cigarette smoke inhibition of ion transport in canine tracheal epithelium. , 1983, The Journal of clinical investigation.
[43] C. Schultz,et al. Neutrophil elastase and matrix metalloproteinase 12 in cystic fibrosis lung disease , 2016, Molecular and Cellular Pediatrics.
[44] M. Kuehn,et al. Naturally Produced Outer Membrane Vesicles from Pseudomonas aeruginosa Elicit a Potent Innate Immune Response via Combined Sensing of Both Lipopolysaccharide and Protein Components , 2010, Infection and Immunity.
[45] L. Dupont,et al. Treatment burden in patients with at least one class IV or V CFTR mutation , 2015, Pediatric pulmonology.
[46] C. Reilly,et al. Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[47] M. Schechter. Non-Genetic Influences on Cystic Fibrosis Lung Disease: The Role of Sociodemographic Characteristics, Environmental Exposures, and Healthcare Interventions , 2003, Seminars in respiratory and critical care medicine.
[48] S. Lynch,et al. The cystic fibrosis airway microbiome. , 2013, Cold Spring Harbor perspectives in medicine.
[49] T. Stockner,et al. Pharmacological correction of misfolding of ABC proteins☆ , 2014, Drug discovery today. Technologies.
[50] Q. Wang,et al. Neutrophils sense microbial size and selectively release neutrophil extracellular traps in response to large pathogens , 2014, Nature Immunology.
[51] L. Raskin,et al. Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples , 2016, PloS one.
[52] L. G. Johnson,et al. Gene therapy for cystic fibrosis. , 1995, Chest.
[53] T. Biedermann,et al. Invariant Natural Killer T (iNKT) Cells Prevent Autoimmunity, but Induce Pulmonary Inflammation in Cystic Fibrosis , 2014, Cellular Physiology and Biochemistry.
[54] S. Sagel,et al. The airway microbiome in cystic fibrosis and implications for treatment , 2011, Current opinion in pediatrics.
[55] J. Wine,et al. Airway Gland Structure and Function. , 2015, Physiological reviews.
[56] Christian Cambillau,et al. Architecture and assembly of the Type VI secretion system. , 2014, Biochimica et biophysica acta.
[57] M. Amaral,et al. Deletion of Phe508 in the first nucleotide‐binding domain of the cystic fibrosis transmembrane conductance regulator increases its affinity for the heat shock cognate 70 chaperone , 2009, The FEBS journal.
[58] Zhengrong Yang,et al. Thermal unfolding studies show the disease causing F508del mutation in CFTR thermodynamically destabilizes nucleotide‐binding domain 1 , 2010, Protein science : a publication of the Protein Society.
[59] G. Cutting,et al. Self-reported exercise and longitudinal outcomes in cystic fibrosis: a retrospective cohort study , 2014, BMC Pulmonary Medicine.
[60] Lian-Hui Zhang,et al. Cis-2-dodecenoic acid signal modulates virulence of Pseudomonas aeruginosa through interference with quorum sensing systems and T3SS , 2013, BMC Microbiology.
[61] S. Ye,et al. Pseudomonas aeruginosa Cif Protein Enhances the Ubiquitination and Proteasomal Degradation of the Transporter Associated with Antigen Processing (TAP) and Reduces Major Histocompatibility Complex (MHC) Class I Antigen Presentation* , 2013, The Journal of Biological Chemistry.
[62] S. Lory,et al. Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[63] J. Curtis,et al. Application of a Neutral Community Model To Assess Structuring of the Human Lung Microbiome , 2015, mBio.
[64] M. Schechter. Wealth as a disease modifier in cystic fibrosis. , 2013, The Lancet Respiratory Medicine.
[65] H. Gendelman,et al. Cell delivery of therapeutic nanoparticles. , 2011, Progress in molecular biology and translational science.
[66] D. Leduc,et al. Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity , 2014, Nature Communications.
[67] G. Dubourg,et al. Microbiota manipulation for weight change. , 2017, Microbial pathogenesis.
[68] Eoin L. Brodie,et al. Loss of Bacterial Diversity during Antibiotic Treatment of Intubated Patients Colonized with Pseudomonas aeruginosa , 2006, Journal of Clinical Microbiology.
[69] J. Wakefield,et al. Fine particulate matter exposure and initial Pseudomonas aeruginosa acquisition in cystic fibrosis. , 2015, Annals of the American Thoracic Society.
[70] B. Tümmler,et al. The cystic fibrosis lower airways microbial metagenome , 2016, ERJ Open Research.
[71] N. Joo,et al. Submucosal glands and airway defense. , 2004, Proceedings of the American Thoracic Society.
[72] F. Jerry Reen,et al. A new regulator of pathogenicity (bvlR) is required for full virulence and tight microcolony formation in Pseudomonas aeruginosa. , 2014, Microbiology.
[73] S. Sagel,et al. Cystic fibrosis: a model system for precision medicine , 2016, Current opinion in pediatrics.
[74] S. D. Davidson Ward,et al. Effect of residential proximity to major roadways on cystic fibrosis exacerbations , 2013, International journal of environmental health research.
[75] Scott R. Miller,et al. Genotypic and Phenotypic Variation in Pseudomonas aeruginosa Reveals Signatures of Secondary Infection and Mutator Activity in Certain Cystic Fibrosis Patients with Chronic Lung Infections , 2011, Infection and Immunity.
[76] I. Novak,et al. Purinergic regulation of CFTR and Ca(2+)-activated Cl(-) channels and K(+) channels in human pancreatic duct epithelium. , 2013, American journal of physiology. Cell physiology.
[77] S. Donaldson,et al. Lung microbiota across age and disease stage in cystic fibrosis , 2015, Scientific Reports.
[78] D. Goodlett,et al. A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria. , 2010, Cell host & microbe.
[79] Adrian W. R. Serohijos,et al. Phenylalanine-508 mediates a cytoplasmic–membrane domain contact in the CFTR 3D structure crucial to assembly and channel function , 2008, Proceedings of the National Academy of Sciences.
[80] R. Castile,et al. Detrimental effects of secondhand smoke exposure on infants with cystic fibrosis , 2015, Pediatric pulmonology.
[81] M. Corey,et al. High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial. , 2007, The Journal of pediatrics.
[82] K. Hamilton,et al. Ion Channels and Transporters of Epithelia in Health and Disease , 2016, Physiology in Health and Disease.
[83] D. Benos,et al. The cytosolic termini of the beta- and gamma-ENaC subunits are involved in the functional interactions between cystic fibrosis transmembrane conductance regulator and epithelial sodium channel. , 2000, Journal of Biological Chemistry.
[84] A. Hauser. The type III secretion system of Pseudomonas aeruginosa: infection by injection , 2009, Nature Reviews Microbiology.
[85] Michael G. Surette,et al. Discerning the Complexity of Community Interactions Using a Drosophila Model of Polymicrobial Infections , 2008, PLoS pathogens.
[86] D. Hartl,et al. Current concepts of immune dysregulation in cystic fibrosis. , 2014, The international journal of biochemistry & cell biology.
[87] D. Benos,et al. The Cytosolic Termini of the β- and γ-ENaC Subunits Are Involved in the Functional Interactions between Cystic Fibrosis Transmembrane Conductance Regulator and Epithelial Sodium Channel , 2000 .
[88] M. Karagas,et al. Associations between Gut Microbial Colonization in Early Life and Respiratory Outcomes in Cystic Fibrosis. , 2015, The Journal of pediatrics.
[89] R. Turner,et al. New developments in the epidemiology and clinical spectrum of rhinovirus infections , 2008, Current opinion in pediatrics.
[90] J. Sturgess,et al. A reconstruction of the duct system and secretory tubules of the human bronchial submucosal gland , 1969, Thorax.
[91] M. Wjst,et al. Decreased expression of HLA-DQ and HLA-DR on cells of the monocytic lineage in cystic fibrosis , 2014, Journal of Molecular Medicine.
[92] G. Sawicki,et al. Managing treatment complexity in cystic fibrosis: Challenges and Opportunities , 2012, Pediatric pulmonology.
[93] Eoin L. Brodie,et al. Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients , 2010, PloS one.
[94] J. Adjemian,et al. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. , 2013, American journal of respiratory and critical care medicine.
[95] A. Meinhart,et al. Structural Insights into the Effector – Immunity System Tse1/Tsi1 from Pseudomonas aeruginosa , 2012, PloS one.
[96] Jan Michiels,et al. Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. , 2011, Journal of medical microbiology.
[97] G. Pier,et al. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[98] C. Bear,et al. Facilitating Structure-Function Studies of CFTR Modulator Sites with Efficiencies in Mutagenesis and Functional Screening , 2015, Journal of biomolecular screening.
[99] G. Kroemer,et al. Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis , 2016, Molecular and Cellular Pediatrics.
[100] J. Wells,et al. Generating human intestinal tissues from pluripotent stem cells to study development and disease , 2015, The EMBO journal.
[101] J. Lo-Guidice,et al. Human airway mucin glycosylation: A combinatory of carbohydrate determinants which vary in cystic fibrosis , 2001, Glycoconjugate Journal.
[102] C. Goss,et al. Tackling the increasing complexity of CF care , 2015, Pediatric pulmonology.
[103] Atropine or Glycopyrrolate with Neostigmine 5 mg: A Comparative Dose-Response Study , 1986 .
[104] Isabelle Callebaut,et al. Molecular models of the open and closed states of the whole human CFTR protein , 2009, Cellular and Molecular Life Sciences.
[105] C. Barry,et al. Iron Acquisition and Metabolism by Mycobacteria , 1999, Journal of bacteriology.
[106] Lars Kaderali,et al. Comparison of Microbiomes from Different Niches of Upper and Lower Airways in Children and Adolescents with Cystic Fibrosis , 2015, PloS one.
[107] Philip J. Thomas,et al. Requirements for Efficient Correction of ΔF508 CFTR Revealed by Analyses of Evolved Sequences , 2012, Cell.
[108] J. Stroobant. Viral infection in cystic fibrosis. , 1986, Journal of the Royal Society of Medicine.
[109] Waldemar Vollmer,et al. Type VI secretion delivers bacteriolytic effectors to target cells , 2011, Nature.
[110] M. Henry,et al. A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy. , 2014, Blood.
[111] D. Ohman,et al. Identification of Genes in the σ22 Regulon of Pseudomonas aeruginosa Required for Cell Envelope Homeostasis in Either the Planktonic or the Sessile Mode of Growth , 2012, mBio.
[112] R. Ramphal,et al. Toll-like receptor 5 (TLR5), IL-1β secretion, and asparagine endopeptidase are critical factors for alveolar macrophage phagocytosis and bacterial killing , 2012, Proceedings of the National Academy of Sciences.
[113] R. Denny,et al. Recent developments in targeting protein misfolding diseases. , 2013, Bioorganic & medicinal chemistry letters.
[114] M. Surette,et al. Hybrid sensor kinase PA1611 in Pseudomonas aeruginosa regulates transitions between acute and chronic infection through direct interaction with RetS , 2013, Molecular microbiology.
[115] J. Beekman,et al. Effects of Aspergillus fumigatus colonization on lung function in cystic fibrosis , 2012, Current opinion in pulmonary medicine.
[116] R. Szczesniak,et al. Adolescents' Spirituality and Cystic Fibrosis Airway Clearance Treatment Adherence: Examining Mediators. , 2016, Journal of pediatric psychology.
[117] E. Alton,et al. Gene therapy for cystic fibrosis: recent progress and current aims , 2016 .
[118] M. Corboz,et al. Effect of anion transport inhibition on mucus secretion by airway submucosal glands. , 1997, The American journal of physiology.
[119] Richard Bonneau,et al. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome , 2010, Proceedings of the National Academy of Sciences.
[120] N. Joo,et al. Mucus Secretion from Single Submucosal Glands of Pig , 2002, The Journal of Biological Chemistry.
[121] E. Mahenthiralingam. Emerging cystic fibrosis pathogens and the microbiome. , 2014, Paediatric respiratory reviews.
[122] G. Sawicki,et al. Treatment complexity in cystic fibrosis: trends over time and associations with site-specific outcomes. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[123] Paola Vergani,et al. CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains , 2005, Nature.
[124] Alison Gifford,et al. The role of neutrophils in cystic fibrosis , 2014, Current opinion in hematology.
[125] A. Buckling,et al. Pre‐adapting parasitic phages to a pathogen leads to increased pathogen clearance and lowered resistance evolution with Pseudomonas aeruginosa cystic fibrosis bacterial isolates , 2016, Journal of evolutionary biology.
[126] Sukhmani Kaur,et al. Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment , 2016, Stem cells international.
[127] A. Kharazmi,et al. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis , 2009, Thorax.
[128] Ming Ding,et al. Bone Formation by Sheep Stem Cells in an Ectopic Mouse Model: Comparison of Adipose and Bone Marrow Derived Cells and Identification of Donor-Derived Bone by Antibody Staining , 2016, Stem cells international.
[129] S. Peltz,et al. PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model , 2008, Proceedings of the National Academy of Sciences.
[130] M. Welsh,et al. Reduced Airway Surface pH Impairs Bacterial Killing in the Porcine Cystic Fibrosis Lung , 2012, Nature.
[131] E. Bingen,et al. Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization , 2001, Pediatric pulmonology.
[132] A. Oliver. Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapy. , 2010, International journal of medical microbiology : IJMM.
[133] T. DeSantis,et al. The Microbial Community of the Cystic Fibrosis Airway Is Disrupted in Early Life , 2014, PloS one.
[134] K. Cheung,et al. Synergistic Effects of Cystic Fibrosis Transmembrane Conductance Regulator and Aquaporin-9 in the Rat Epididymis1 , 2003, Biology of reproduction.
[135] J. Emerson,et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis , 2002, Pediatric pulmonology.
[136] D. Murphy,et al. Ivacaftor in a G551D homozygote with cystic fibrosis. , 2013, The New England journal of medicine.
[137] Yishan Luo,et al. Staphylococcus aureus Inhibits IL-8 Responses Induced by Pseudomonas aeruginosa in Airway Epithelial Cells , 2015, PloS one.
[138] J. Norris,et al. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening , 2003, Pediatric pulmonology.
[139] J. Davies,et al. Recent advances in the management of cystic fibrosis , 2014, Archives of Disease in Childhood.
[140] M. Surette,et al. Cystic fibrosis: a polymicrobial infectious disease. , 2006, Future microbiology.
[141] D. Meyerholz. Lessons learned from the cystic fibrosis pig. , 2016, Theriogenology.
[142] K. Lewis,et al. Persister cells. , 2010, Annual review of microbiology.
[143] D. Geddes,et al. Airway surface pH in subjects with cystic fibrosis , 2003, European Respiratory Journal.
[144] D. Borowitz. CFTR, bicarbonate, and the pathophysiology of cystic fibrosis , 2015, Pediatric pulmonology.
[145] P. Russo,et al. Rheological Properties of Cystic Fibrosis Bronchial Secretion and in Vitro Drug Permeation Study: The Effect of Sodium Bicarbonate. , 2016, Journal of aerosol medicine and pulmonary drug delivery.
[146] Sharon L. Grim,et al. Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis , 2014, Microbiome.
[147] Haitao Wen,et al. The inflammasome NLRs in immunity, inflammation, and associated diseases. , 2011, Annual review of immunology.
[148] S. Leroy,et al. The Airway Microbiota in Cystic Fibrosis: A Complex Fungal and Bacterial Community—Implications for Therapeutic Management , 2012, PloS one.
[149] N. Høiby,et al. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. , 1992, Thorax.
[150] G. Gargala,et al. Long-Term Rasamsonia argillacea Complex Species Colonization Revealed by PCR Amplification of Repetitive DNA Sequences in Cystic Fibrosis Patients , 2016, Journal of Clinical Microbiology.
[151] Ajit Varki,et al. Acidic pH increases airway surface liquid viscosity in cystic fibrosis. , 2016, The Journal of clinical investigation.
[152] Jinglan Zhou,et al. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770 , 2009, Proceedings of the National Academy of Sciences.
[153] N. Høiby,et al. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in the Danish Cystic Fibrosis Centre. , 1995, The Journal of hospital infection.
[154] M. Maciá,et al. The problems of antibiotic resistance in cystic fibrosis and solutions , 2015, Expert review of respiratory medicine.
[155] Forest Rohwer,et al. Biogeochemical Forces Shape the Composition and Physiology of Polymicrobial Communities in the Cystic Fibrosis Lung , 2014, mBio.
[156] G. Cutting,et al. Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function. , 2010, The Journal of pediatrics.
[157] D. Stevens,et al. Effect of Media Modified To Mimic Cystic Fibrosis Sputum on the Susceptibility of Aspergillus fumigatus, and the Frequency of Resistance at One Center , 2016, Antimicrobial Agents and Chemotherapy.
[158] F. Taddei,et al. Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis , 2009, Pediatric pulmonology.
[159] Xiaohong Huang,et al. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. , 2015, The New England journal of medicine.
[160] Andrea M. Smania,et al. Coexistence and Within-Host Evolution of Diversified Lineages of Hypermutable Pseudomonas aeruginosa in Long-term Cystic Fibrosis Infections , 2014, PLoS genetics.
[161] D. Willner,et al. Metagenomics and metatranscriptomics: windows on CF-associated viral and microbial communities. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[162] A. Gaggar,et al. Innate immunity in cystic fibrosis lung disease. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[163] S. Rand,et al. Exercise as part of a cystic fibrosis therapeutic routine , 2012, Expert review of respiratory medicine.
[164] L. Delhaes,et al. Fungal respiratory infections in cystic fibrosis: a growing problem. , 2010, Medical mycology.
[165] C. Wielinski,et al. Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years. , 1993, The Journal of pediatrics.
[166] G. Rogers,et al. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition , 2013, Thorax.
[167] Eric P. Skaar,et al. Iron in infection and immunity. , 2013, Cell host & microbe.
[168] J. Clancy. Cystic Fibrosis Transmembrane Conductance Regulator Function in Airway Smooth Muscle. A Novel Role in Cystic Fibrosis Airway Obstruction. , 2016, American journal of respiratory and critical care medicine.
[169] Jace W. Jones,et al. Iron Depletion Enhances Production of Antimicrobials by Pseudomonas aeruginosa , 2015, Journal of bacteriology.
[170] C. Férec,et al. Evidence for decline in the incidence of cystic fibrosis: a 35-year observational study in Brittany, France , 2012, Orphanet Journal of Rare Diseases.
[171] George P Patrinos,et al. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene , 2013, Nature Genetics.
[172] Richard C Boucher,et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.
[173] Y. Berthiaume,et al. Regulation of ENaC and CFTR expression with K+ channel modulators and effect on fluid absorption across alveolar epithelial cells. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[174] G. Giebisch,et al. CFTR is required for PKA-regulated ATP sensitivity of Kir1.1 potassium channels in mouse kidney. , 2006, The Journal of clinical investigation.
[175] H. Hoogsteden,et al. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial. , 2014, The Lancet. Respiratory medicine.
[176] H. Forman,et al. Abnormal glutathione transport in cystic fibrosis airway epithelia. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[177] D. Wat,et al. The role of respiratory viruses in cystic fibrosis , 2008, Journal of Cystic Fibrosis.
[178] K. Du,et al. Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ΔF508 CFTR Folding and Function , 2012, Cell.
[179] H. Ackermann,et al. Prevalence and Clinical Significance of Staphylococcus aureus Small-Colony Variants in Cystic Fibrosis Lung Disease , 2006, Journal of Clinical Microbiology.
[180] Morgan L. Maeder,et al. Genome-editing Technologies for Gene and Cell Therapy , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.
[181] C. Higgins,et al. Immunocytochemical localization of the cystic fibrosis gene product CFTR. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[182] A. Fodor,et al. The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations , 2012, PloS one.
[183] M. Surette,et al. Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication , 2003, Molecular microbiology.
[184] P. Diot,et al. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum. , 2012, American journal of respiratory cell and molecular biology.
[185] J. Gatzy,et al. Acetylcholine-induced liquid secretion by bronchial epithelium: role of Cl- and[Formula: see text] transport. , 1998, American journal of physiology. Lung cellular and molecular physiology.
[186] A. Oliver,et al. Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[187] Andrew M. Jones,et al. The Microbiome and Emerging Pathogens in Cystic Fibrosis and Non–Cystic Fibrosis Bronchiectasis , 2015, Seminars in Respiratory and Critical Care Medicine.
[188] J. Gatzy,et al. Acetylcholine-induced liquid secretion by bronchial epithelium: role of Cl- and HCO3- transport. , 1998, The American journal of physiology.
[189] Zaid Abdo,et al. The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation , 2015, Microbiome.
[190] Forest Rohwer,et al. Metagenomic Analysis of Respiratory Tract DNA Viral Communities in Cystic Fibrosis and Non-Cystic Fibrosis Individuals , 2009, PloS one.
[191] K. Lewis. Persister cells: molecular mechanisms related to antibiotic tolerance. , 2012, Handbook of Experimental Pharmacology.
[192] H. Malech,et al. Release of Cystic Fibrosis Airway Inflammatory Markers from Pseudomonas aeruginosa–Stimulated Human Neutrophils Involves NADPH Oxidase-Dependent Extracellular DNA Trap Formation , 2014, The Journal of Immunology.
[193] M. Wolfgang,et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. , 2008, American journal of respiratory and critical care medicine.
[194] B. Harvey,et al. Bile acids stimulate chloride secretion through CFTR and calcium-activated Cl- channels in Calu-3 airway epithelial cells. , 2014, American journal of physiology. Lung cellular and molecular physiology.
[195] David J. Evans,et al. Pseudomonas aeruginosa-Induced Bleb-Niche Formation in Epithelial Cells Is Independent of Actinomyosin Contraction and Enhanced by Loss of Cystic Fibrosis Transmembrane-Conductance Regulator Osmoregulatory Function , 2015, mBio.
[196] J. Heesemann,et al. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung. , 2013, Current topics in microbiology and immunology.
[197] J. Jansson,et al. Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonization , 2015, SpringerPlus.
[198] Lucas Smith,et al. Phenotypic Characterization of Clonal and Nonclonal Pseudomonas aeruginosa Strains Isolated from Lungs of Adults with Cystic Fibrosis , 2007, Journal of Clinical Microbiology.
[199] Rosemary C. She,et al. Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa. , 2016, The Journal of antimicrobial chemotherapy.
[200] N. Høiby,et al. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic. , 1983, The Journal of hospital infection.
[201] L. Reid,et al. Ultrastructure of cells in the human bronchial submucosal glands. , 1970, Journal of anatomy.
[202] Meenu Singh,et al. CD4+CD25 high FOXP3+ Regulatory T Cells Correlate with FEV1 in North Indian Children with Cystic Fibrosis , 2014, Immunological investigations.
[203] Hans Clevers,et al. A functional CFTR assay using primary cystic fibrosis intestinal organoids , 2013, Nature Medicine.
[204] I. Crandall,et al. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. , 2011, American journal of respiratory and critical care medicine.
[205] D. Gadsby,et al. Strict coupling between CFTR’s catalytic cycle and gating of its Cl− ion pore revealed by distributions of open channel burst durations , 2009, Proceedings of the National Academy of Sciences.
[206] G. Nagel,et al. Non‐specific activation of the epithelial sodium channel by the CFTR chloride channel , 2001, EMBO reports.
[207] M. Knowles,et al. Evidence for reduced Cl‐ and increased Na+ permeability in cystic fibrosis human primary cell cultures. , 1988, The Journal of physiology.
[208] V. Waters,et al. Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections. , 2014, Annals of the American Thoracic Society.
[209] S. McColley,et al. Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis , 2011, Clinical Microbiology Reviews.
[210] G. Huffnagle,et al. The bacterial microbiota in inflammatory lung diseases. , 2015, Clinical immunology.
[211] S. Lewis,et al. Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: a comparative efficacy trial. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[212] Garth D. Ehrlich,et al. Oxygen Limitation Contributes to Antibiotic Tolerance of Pseudomonas aeruginosa in Biofilms , 2004, Antimicrobial Agents and Chemotherapy.
[213] P. Leprohon,et al. Diverse Virulent Pneumophages Infect Streptococcus mitis , 2015, PloS one.
[214] S. Leeper-Woodford,et al. Acute hypoxia increases alveolar macrophage tumor necrosis factor activity and alters NF-κB expression. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[215] C. Merlo,et al. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. , 2008, American journal of respiratory and critical care medicine.
[216] M. Surette,et al. McKay agar enables routine quantification of the 'Streptococcus milleri' group in cystic fibrosis patients. , 2010, Journal of medical microbiology.
[217] Christian Koch,et al. Early infection and progression of cystic fibrosis lung disease , 2002, Pediatric pulmonology.
[218] David K. Meyerholz,et al. Airway acidification initiates host defense abnormalities in cystic fibrosis mice , 2016, Science.
[219] Jordi Villà-Freixa,et al. New Model of Cystic Fibrosis Transmembrane Conductance Regulator Proposes Active Channel-like Conformation , 2012, J. Chem. Inf. Model..
[220] M. Welsh,et al. Neonates with cystic fibrosis have a reduced nasal liquid pH; a small pilot study. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[221] J. Parkhill,et al. Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention , 2015, The ISME Journal.
[222] R. Dawson,et al. Structure of a bacterial multidrug ABC transporter , 2006, Nature.
[223] Karen A Robinson,et al. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. , 2007, American journal of respiratory and critical care medicine.
[224] Szilvia Szép,et al. The antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseases , 2009, Proceedings of the National Academy of Sciences.
[225] E. Schwiebert,et al. Differential expression of ORCC and CFTR induced by low temperature in CF airway epithelial cells. , 1995, The American journal of physiology.
[226] A. Prince,et al. Cystic fibrosis: a mucosal immunodeficiency syndrome , 2012, Nature Medicine.
[227] M. Knowles,et al. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. , 2006, The New England journal of medicine.
[228] P. Thomas,et al. CFTR and Cystic Fibrosis , 2015 .
[229] James M. Wilson,et al. Submucosal glands are the predominant site of CFTR expression in the human bronchus , 1992, Nature Genetics.
[230] L. Lynd,et al. Coculture of Staphylococcus aureus with Pseudomonas aeruginosa Drives S. aureus towards Fermentative Metabolism and Reduced Viability in a Cystic Fibrosis Model , 2015, Journal of bacteriology.
[231] M. Surette,et al. Clinical Insights into Pulmonary Exacerbations in Cystic Fibrosis from the Microbiome. What Are We Missing? , 2015, Annals of the American Thoracic Society.
[232] S. McGrath-Morrow,et al. Environmental Research and Public Health the Impact of Secondhand Smoke Exposure on Children with Cystic Fibrosis: a Review , 2022 .
[233] A. Amer,et al. IFN-γ Stimulates Autophagy-Mediated Clearance of Burkholderia cenocepacia in Human Cystic Fibrosis Macrophages , 2014, PloS one.
[234] J. Stockman. Effect of Azithromycin on Pulmonary Function in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosa: A Randomized Controlled Trial , 2012 .
[235] Roger Marthan,et al. Bronchial measurement with three-dimensional quantitative thin-section CT in patients with cystic fibrosis. , 2007, Radiology.
[236] M. Surette,et al. The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture. , 2011, Canadian journal of microbiology.
[237] T. Yamaguchi,et al. Clara cell protein-positive epithelial cells are reduced in small airways of asthmatics. , 1999, American journal of respiratory and critical care medicine.